Reduced amylin levels are associated with low bone mineral density in women with anorexia nervosa
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Context Anorexia nervosa, characterized by extreme low body weight due to reduced nutrient intake, is associated with severe bone loss. Peptide hormones, including amylin, GIP, and GLP2, are released immediately after nutrient intake and may be involved in the regulation of bone turnover. Objective To investigate fasting levels of amylin, GIP, and GLP2 and their relationships with bone mineral density (BMD) in women with anorexia nervosa compared to healthy controls. Design Cross-sectional Setting Clinical Research Center Study Participants 15 women with anorexia nervosa and 16 healthy controls Intervention None Main Outcome Measures Fasting serum amylin, GIP, and GLP2, and BMD Results Women with anorexia nervosa had significantly lower fasting serum amylin and GIP levels than healthy controls. Fasting serum GLP2 levels were not significantly different between groups. Fasting amylin levels were positively associated with BMD and Z-score at the PA spine, total hip, and femoral neck. Fasting amylin levels were also positively associated with weight and percent fat; after controlling for these variables, amylin was still a significant predictor of BMD and Z-score at the femoral neck and of Z-score at the total hip. In the anorexia nervosa group, there was a trend toward an inverse association between amylin and C-terminal telopeptide (CTX) levels (R = −0.47, p = 0.08). GIP and GLP2 levels did not predict BMD at any site. Conclusion Decreased secretion of amylin may be a mechanism through which reduced nutrient intake adversely affects BMD in anorexia nervosa.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cooper, G. J., Willis, A. C., Clark, A., Turner, R. C., Sim, R. B., & Reid, K. B. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.23.8628 · Cited by 1,299 · cited 1×
“Amylin, a peptide hormone co-secreted with insulin from pancreatic beta cells [5,6], has been shown to stimulate bone formation and decrease bone resorption, via its action on osteoblasts and osteoclasts, respectively, in animal models and cell culture experiments [7,8].”
Amylin inhibits bone resorption while the calcitonin receptor controls bone formation in vivo
Dacquin, R., Davey, R. A., Laplace, C., Levasseur, R., Morris, H. A., Goldring, S. R., Gebre-Medhin, S., Galson, D. L., Zajac, J. D., & Karsenty, G. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200312135 · Cited by 206 · cited 2×
“Indeed, amylin-deficient mice have a low bone mass phenotype [19] and decreased trabecular volume and number [21].”
Effects of calcitonin, amylin, and calcitonin gene-related peptide on osteoclast development
Cornish, J., Callon, K. E., Bava, U., Kamona, S. A., Cooper, G. J. S., & Reid, I. R. (2001) · Bone · doi:10.1016/s8756-3282(01)00494-x · Cited by 173 · cited 1×
“Amylin has also been shown to compromise osteoclast motility [16,17] and differentiation [18,19] in rodent cell cultures, and to decrease osteoclast resorptive activity [18,20].”
Amylin Stimulates Osteoblast Proliferation and Increases Mineralized Bone Volume in Adult Mice
Cornish, J., Callon, K. E., Cooper, G. J. S., & Reid, I. R. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.1163 · Cited by 126
Cornish, J., Callon, K. E., King, A. R., Cooper, G. J. S., & Reid, I. R. (1998) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1998.275.4.e694 · Cited by 102 · cited 1×
“histomorphometric indices of bone formation and reduce indices of bone resorption in mice [10,22].”
Amylin inhibits bone resorption by a direct effect on the motility of rat osteoclasts
Alam, A., Moonga, B., Bevis, P., Huang, C., & Zaidi, M. (1993) · Experimental Physiology · doi:10.1113/expphysiol.1993.sp003679 · Cited by 99 · cited 1×
“Amylin has also been shown to compromise osteoclast motility [16,17] and differentiation [18,19] in rodent cell cultures, and to decrease osteoclast resorptive activity [18,20].”
AMYLINAMIDE, BONE CONSERVATION, AND PANCREATIC β CELLS
Macintyre, I. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91028-3 · Cited by 56 · cited 1×
“Amylin, a peptide hormone co-secreted with insulin from pancreatic beta cells [5,6], has been shown to stimulate bone formation and decrease bone resorption, via its action on osteoblasts and osteoclasts, respectively, in animal models and cell culture experiments [7,8].”
Dissociation of the effects of amylin on osteoblast proliferation and bone resorption
Cornish, J., Callon, K. E., Lin, C. Q.-X., Xiao, C. L., Mulvey, T. B., Coy, D. H., Cooper, G. J. S., & Reid, I. R. (1998) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1998.274.5.e827 · Cited by 54
Effects of Amylin on Human Osteoblast-Like Cells
Villa, I., Rubinacci, A., Ravasi, F., Ferrara, A. F., & Guidobono, F. (1997) · Peptides · doi:10.1016/s0196-9781(97)00056-9 · Cited by 45
Pietschmann, P., Farsoudi, K. H., Hoffmann, O., Klaushofer, K., Hörandner, H., & Peterlik, M. (1993) · Bone · doi:10.1016/8756-3282(93)90244-5 · Cited by 28 · cited 1×
“Amylin has also been shown to compromise osteoclast motility [16,17] and differentiation [18,19] in rodent cell cultures, and to decrease osteoclast resorptive activity [18,20].”
Effects of Amylin Deficiency on Trabecular Bone in Young Mice Are Sex-Dependent
Davey, R. A., Moore, A. J., Chiu, M. W. S., Notini, A. J., Morris, H. A., & Zajac, J. D. (2006) · Calcified Tissue International · doi:10.1007/s00223-005-0286-2 · Cited by 25 · cited 1×
“Indeed, amylin-deficient mice have a low bone mass phenotype [19] and decreased trabecular volume and number [21].”
Cited by
Endocrine consequences of anorexia nervosa
Misra, M., & Klibanski, A. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70180-3 · Cited by 341
Self-citationEndocrine Effects of Relative Energy Deficiency in Sport
Elliott-Sale, K. J., Tenforde, A. S., Parziale, A. L., Holtzman, B., & Ackerman, K. E. (2018) · International Journal of Sport Nutrition and Exercise Metabolism · doi:10.1123/ijsnem.2018-0127 · Cited by 229
Solmi, M., Veronese, N., Correll, C. U., Favaro, A., Santonastaso, P., Caregaro, L., Vancampfort, D., Luchini, C., De Hert, M., & Stubbs, B. (2016) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12556 · Cited by 124
“0001, I(2) = 83%), and femoral neck BMD (31, 34, 36, 38, 39, 44, 52, 54, 56, 60, 61, 68, 72, 76, 79, 83, 84, 86, 87) (studies = 20; SMD = 0.”
Metadata
- Authors
- Wojcik, M. H., Meenaghan, E., Lawson, E. A., Misra, M., Klibanski, A., & Miller, K. K.
- Venue
- Bone
- Publisher
- Elsevier BV
- Published
- 2010-03
- Volume
- 46
- Issue
- 3
- Pages
- 796-800
- ISSN
- 1873-2763 (ISSN-L)
- 8756-3282
- OpenAlex
- W2038426107
- Cited by
- 39
- References
- 11
- FWCI
- 2.24
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.